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Summary
sudden respiratory distress in association with severe 
weight loss are unusual features of systemic sclerosis 
(ssc). We report the case of a 56-year-old Caucasian 
woman with a 9-year history of a diffuse form of ssc 
who presented with acute stridor due to vocal cord 
paralysis and required an emergency tracheostomy. 
she had sought medical attention only after 4 years of 
disease onset, presenting with a mask-like face, diffuse 
skin thickening, acro-osteolysis and severe interstitial 
lung disease. even though skin tightness improved after 
immunosuppressive treatment, several spontaneous 
facial fractures and episodes of dysphagia and choking 
occurred in the years that followed. at the time of stridor, 
she was severely malnourished and a percutaneous 
endoscopic gastrostomy was required for feeding. 
permanent vocal cord damage in combination with 
severe loco-regional bone resorption resulted in severe 
disability and impaired nutrition. We hereby highlight the 
features of ssc for which therapy remains challenging.
BaCkground 
Mandibular resorption and vocal cord paralysis are 
recognised features of systemic sclerosis (SSc), both 
likely to be driven by vasculopathy and peripheral 
ischaemia.1 2 Facial skin thickening and muscular 
atrophy contribute to bone resorption.3 In turn, 
laryngeal inflammation has been attributed to 
gastro-oesophageal reflux, vocal fold thickening, 
nodularity or fibrosis,4 5 while vocal cord paralysis 
has been related to cricoarytenoid ankyloses and 
nerve injury.6 7 According to literature, mandibular 
resorption in SSc has a variable prevalence raising 
from 6.6% to 46.7%,3 and it correlates with longer 
disease duration. Most evidence comes from case 
reports and small case series, in which mandibular 
resorption is not related to a specific serological 
pattern. It may involve temporomandibular joint 
and clinical manifestations vary from any symptoms 
to severe pain and mouth opening limitation. Due 
to its consequences, early detection is crucial and 
active pursuing of mandibular involvement in SSc 
patients has been recommended.8 
Vocal cord paralysis seems to be extremely rare 
in SSc and few cases were reported6; thus estima-
tion of real prevalence and clinical and serolog-
ical correlates is challenging. Coexistence of these 
two rare and severe complications in an individual 
patient has not been previously described. This 
report highlights a unique combination of almost 
untreatable SSc orofacial manifestations with high 
morbidity and impact on patient’s quality of life.
CaSe preSenTaTion
In April 2017, a 56-year-old woman with a 9-year 
history of a diffuse form of SSc presented with acute 
stridor. Laryngoscopy showed macroscopically 
normal vocal cords in a nearly adducted position 
and an emergency tracheostomy was performed. 
Disease onset had been characterised by generalised 
skin thickening at age 47 but the patient had sought 
medical attention only at age 51. She had a mask-
like face, microstomia, limited and painful jaw 
movements, salt and pepper skin, acro-osteolysis, 
a chronic cough and recent onset effort dyspnoea. 
She was unable to lift her arms and had difficulty 
with self-care and daily activities. The modified 
Rodnan skin score (mRSS) was 42 and the left wrist 
was inflamed and immobile. Complete blood count 
and biochemistry profile were normal. Further tests 
revealed a high erythrocyte sedimentation rate 
(ESR) (72 mm/hour); the antinuclear antibody test 
was positive with a nucleolar pattern and a titre of 
1/640; the immunoblot (Euroimmun@) revealed 
a 3+positivity for anti-topoisomerase I antibody. 
Other features included a late scleroderma capil-
laroscopy pattern, a large calcific deposit in the left 
wrist, extensive non-specific interstitial pneumonia 
(NSIP), a restrictive pattern in the respiratory func-
tion tests (Tiffeneau index of 86%; forced vital 
capacity of 1.97 L units [75% of predicted]; carbon 
monoxide diffusing capacity adjusted for alveolar 
volume (DLCO/VA) of 0.6 mmol/min/kPa/L [35% 
of predicted]) and diffuse oesophageal dilatation. 
Echocardiography was suggestive of pulmonary 
arterial hypertension but this was not confirmed on 
right heart catheterisation. The patient declined to 
take a daily dose of prednisolone. She was initially 
treated with a proton pump inhibitor (PPI), daily 
bosentan and monthly intravenous cyclophos-
phamide (750 mg/m2) for 6 months, after which 
she started mycophenolate mofetil (MMF) 1.5 g/
day. Improvement was documented with an mRSS 
decrease to 20 and lung function stabilisation.
At age 53, the patient reported episodes of 
choking and swallowing difficulties. There was 
neither dysphonia nor hoarseness. In the following 
months, spontaneous fractures of the left mandib-
ular ramus and symphysis occurred. No bisphos-
phonates had ever been prescribed and bone 
densitometry was normal. In January 2017, she still 
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was on MMF (1.5 g/day), but experienced worsening of periph-
eral arthritis and respiratory function tests. For this reason, a 
switch to subcutaneous tocilizumab (162 mg/week) was made. 
Tocilizumab is a monoclonal anti-interleukin 6 (IL-6) receptor-α 
antibody and, even if it is still used as an off-label therapy, it 
seems promising in controlling cutaneous, pulmonary and even 
articular involvement9 10 due to the important role that IL-6 
plays in SSc pathogenesis.11 In our specific situation, tocilizumab 
was chosen considering refractory disease on MMF, aiming to 
stabilise respiratory function and articular disease. The patient 
had temporary relief from her joints complaints. There was 
severe, non-quantified weight loss in 3 months prior to hospital 
admission.
inveSTigaTionS
Facial asymmetry (figure 1A) and retrognathia were associated 
with loss of the mandibular ramus and condyle (figure 1B), as 
showed in CT scan performed with bone 3D reconstruction. 
The hyoid bone remained intact. In addition, CT imaging of the 
neck and thorax failed to reveal any infiltrative lesions or poten-
tial compressive structures in the laryngeal nerve tracts. Medi-
astinal, peri-tracheal and aorto-pulmonary lymph nodes were 
unremarkable. The retrognathia caused marked distortion of the 
pharyngeal anatomy, pushing the epiglottis against the posterior 
pharyngeal wall, partially obstructing the opening of the Eusta-
chian tubes and there was hypoesthesia of the upper larynx. The 
vocal cords were fixed in adduction (figure 1C,D), a finding that 
was confirmed after 6 months on repeated laryngoscopy. Laryn-
geal electromyography is not available in our hospital centre.
differenTial diagnoSiS
Unintentional weight loss might arise from innumerous medical 
conditions and differential diagnosis is wide. In SSc patients, 
specific issues should be addressed. First of all, facial skin 
involvement and bone resorption may heavily disrupt orofacial 
anatomy, with consequences in mouth opening and chewing 
capacity. Teeth can be affected and meticulous oral care is recom-
mended. Xerostomia is common and may interfere with remov-
able dentures use. Moreover, SSc patients may present with 
dysphagia, either due to oropharyngeal muscle involvement or 
due to gastro-oesophageal reflux disease (GERD) and oesoph-
ageal dismotility, limiting oral intake. Small intestine involve-
ment might lead to small intestine bacterial overgrowth (SIBO) 
syndrome that in turn is a cause of malnutrition and weight loss.
In the case we presented, malnutrition and weight loss may 
be multifactorial. Nevertheless, we claim that evolving mandib-
ular resorption and vocal cord paralysis play a major role. The 
patient had known oesophageal involvement as previously 
reported and she was already on PPI and prokinetic drugs, but 
endoscopy performed in April 2017 showed diminished oesoph-
ageal peristalsis, already known, and did not show worsening of 
GERD, gastritis, ulcers or any lesion de novo. She refused barium 
swallow study and more accurate functional motility studies were 
unavailable in our centre. Also, she did not experience any other 
symptoms like bloating, abdominal distension, nausea, vomiting, 
diarrhoea or steatorrhoea nor vitamin deficiencies, making SIBO 
syndrome less probable. A therapeutic challenge with antibiotics 
was made indeed without clinical improvement.
TreaTmenT
When mandibular reabsorption occurred, corrective surgery was 
unfeasible and an oral splint was not tolerated. She was given 
dietary advice—calcium and vitamin D supplements. At the 
time of stridor, she weighed 38 kg (body mass index of 14.8) 
and, due to malnutrition and high aspiration risk, percuta-
neous endoscopic gastrostomy (PEG) was required for feeding. 
Tracheostomy was maintained due to irreversibility of vocal cord 
paralysis.
ouTCome and follow-up
Over the following 18 months, the patient regained and stabilised 
her weight (8 kg since PEG was introduced), showing that orofa-
cial manifestations of SSc and consequent reduced oral intake 
might have been mainly responsible for weight loss. She did not 
develop any clinical manifestation suggesting another underlying 
disease, namely neoplastic, contributing to weight loss. Unfor-
tunately, she suffered from repeated PEG site and respiratory 
tract infections, as a result of which tocilizumab was withdrawn. 
There has been progressive deterioration in lung fibrosis with 
frequent coughing spells. Over the past 6 months, she has taken 
prednisolone 10 mg/day with symptomatic relief. The patient has 
a supportive husband and son and has so far refused any form of 
psychological or psychiatric support. She is closely co-followed 
by the Interstitial Lung Disease and Ear, Nose and Throat Units.
diSCuSSion
The patient displayed severe and disabling manifestations of SSc, 
namely a mask-like face, microstomia, severe skin thickening, 
calcinosis, acro-osteolysis, digital ulcers, interstitial lung disease 
and oesophageal dilatation. Even though this was a late presen-
tation of disease, the initial therapeutic approach reduced skin 
thickness, halted lung inflammation and slightly improved her 
functional status. Of note, she did not receive steroids and there 
was no generalised osteoporosis. When the mandibular fractures 
occurred, no therapeutic option was deemed effective for the 
loco-regional bone resorption, which evolved inexorably with 
total condylolysis and non-union of the mandible. Even though 
surgical reconstruction of temporomandibular joint has been 
successfully performed,12 the patient was considered unfit for 
any intervention. Frequent choking episodes, likely at the origin 
of weight loss, could have contributed to vocal cord dysfunction. 
Instead, we hypothesise that compressive or ischaemic laryngeal 
figure 1 (A) Facial asymmetry and retrognathia; (B) marked facial 
bone resorption as evidenced by the 3D reconstruction of facial CT; (C) 
vocal cord paralysis in non-contrast CT sagittal and (D) coronal views.
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nerve damage is the most likely cause for permanent vocal cord 
paralysis on the basis of anatomical distortion and decreased 
sensation and in the absence of cricoarytenoid or vocal cord 
abnormalities. This report highlights severe orofacial features of 
SSc for which there are no current management guidelines.
learning points
 ► Combined mandibular resorption and vocal cord paralysis 
may occur as a late feature of systemic sclerosis (SSc).
 ► Orofacial manifestations of SSc might be severe and affect 
patients’ quality of life.
 ► Therapeutic options of mandibular resorption remain 
unsatisfactory and patients’ care is a challenge.
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